GeneThera is a biotechnology company that specializes in developing diagnostic tests and vaccines for zoonotic diseases. These are diseases that originate in animals and are capable of causing infectious diseases in humans. More than 80% of all human infectious disease are caused by zoonotic viruses... GeneThera is a biotechnology company that specializes in developing diagnostic tests and vaccines for zoonotic diseases. These are diseases that originate in animals and are capable of causing infectious diseases in humans. More than 80% of all human infectious disease are caused by zoonotic viruses and bacteria. Examples of infectious agents transmitted from animals to humans are, SARS-Cov-2, E.Coli, Mad Cow disease, and Mycobacterium Avium Sub. Paratuberculosis. GeneThera's technology and business model are dedicated to developing the infrastructure of a global network that operates as a Zoonotic Infectious Disease Alert Shield (ZIDAS) to control and prevent pandemics from developing. Genethera's model is based on an Ultrahigh Throughput Molecular Robotic/AI Platform (MORAP) that combines the use of advanced robotic integrated systems with Artificial Intelligence (AI). This technology platform can process millions of samples, collecting, storing, and analyzing data. Genethera has designed a 2nd generation robotic prototype. The system is capable of processing over 100,000 samples/daily with minimum human intervention. Show more
Tue, Sep 10, 2013 12:00 - GeneThera, Inc. (GTHRE: OTCQB) - Symbol Change - The symbol, GTHRE, is no longer a valid symbol for GeneThera, Inc.. As of Tue, Sep 10, 2013, the new trading symbol is...
Applied Genetics Initiates Commercial Operation PR Newswire WESTMINSTER, Colo., June 25, 2012 WESTMINSTER, Colo., June 25, 2012 /PRNewswire/ -- GeneThera Inc. (OTCQB: GTHR) is pleased to announce...
Applied Genetics Signs Agreement With The National University Of Mexico (UNAM) PR Newswire WESTMINSTER, Colo., May 16, 2012 WESTMINSTER, Colo., May 16, 2012 /PRNewswire/ -- GeneThera, Inc...
Applied Genetics Signs Marketing and Sales Agreement with Nutricion Avanzada PR Newswire WESTMINSTER, Colo., Feb. 22, 2012 WESTMINSTER, Colo., Feb. 22, 2012 /PRNewswire/ -- GeneThera Inc...
GeneThera, Inc. Acquires Applied Genetics, S.A. PR Newswire WESTMINSTER, Colo., Jan. 25, 2012 WESTMINSTER, Colo., Jan. 25, 2012 /PRNewswire/ -- GeneThera, Inc. (OTCQB: GTHR) announced today...
WESTMINSTER, CO -- (Marketwire) -- 01/10/12 -- GeneThera, Inc. (OTCQB: GTHR) (PINKSHEETS: GTHR) announced today that Applied Genetics has appointed Dr. Tony Milici as the new Interim President of...
ARVADA, CO -- (Marketwire) -- 09/22/09 -- GeneThera, Inc. (PINKSHEETS: GTHR), an international biotechnology company, today announced it has finalized a license and research agreement with two...
ARVADA, CO -- (Marketwire) -- 08/25/09 -- GeneThera, Inc. (PINKSHEETS: GTHR), an international biotechnology company, today announced a major expansion of its previously reported efforts to...
ARVADA, CO -- (Marketwire) -- 07/23/09 -- GeneThera, Inc. (PINKSHEETS: GTHR) today announced it has retained Pfeiffer High Investor Relations, Inc. to develop and implement a comprehensive...
Results from Pharma Finance 2009 ARVADA, Colo., June 16 /PRNewswire-FirstCall/ -- GeneThera, Inc. (OTC: GTHR.PK). GeneThera, as a service and responsibility to our shareholders, is addressing...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
12 | 0 | 0 | 0.0001 | 0.0001 | 0.0001 | 0 | 0 | CS |
26 | 9.9E-5 | 9900 | 1.0E-6 | 0.0001 | 1.0E-6 | 8242 | 0.0001 | CS |
52 | 9.9E-5 | 9900 | 1.0E-6 | 0.0001 | 1.0E-6 | 6681 | 9.259E-5 | CS |
156 | -0.0449 | -99.7777777778 | 0.045 | 0.068 | 1.0E-6 | 17938 | 0.02543425 | CS |
260 | -0.0069 | -98.5714285714 | 0.007 | 0.47 | 1.0E-6 | 79904 | 0.05688978 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.